The Legacy of HR® Lubricating Jelly dates back to 1925 when the HR® formula was imported from Germany. Soon thereafter, Holland-Rantos began marketing the original "Vaginal Jelly" to be known as HR® Lubricating Jelly.
In the 1940's, the Holland-Rantos Co., and its HR® branded product line was sold to Young's Rubber Co., which manufactured the Trojan Condom.
HR® Lubricating Jelly has been used in a variety of medical applications, including surgical and reproductive therapies, as well as the development of the transcutaneous electrical nerve stimulator in the 1950's. It was first used as a primary echogenic medium for ultrasonic procedures dating back to the early 1960's.
With its rich history in hand, during the 1970's and 1980's, HR® Lubricating Jelly morphed itself into the go to medical lubricant that controlled a significant market share in the medical world. HR® Lubricating Jelly has always been considered a premium medical lubricant that offers a Universal appeal throughout the entire medical community.
In 1985, the HR® brand was sold to Carter-Wallace; in 1999, they ceased operations.
In 2002, the mission to bring HR® Lubricating Jelly began; in 2007 a 32 month historical manufacturing and distribution study ensued. January 2010, HR® Lubricating Jelly achieved Pre-amendment Status by the FDA; this was the first of its kind to be granted since May 28, 1976 when the 510(k) processes began.
In 2012, HR® began offering HR® Lubricating Jelly in several strengths. During the development, HR® reinvented its packaging structure and design to accommodate the patient needs and to give a more modern look to the HR® Lubricating Jelly brand.
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.
© 2008-2019 HR® Pharmaceuticals - Information deemed accurate but not guaranteed. All rights reserved.
